We are live on
!
Find out more
SA
Shilanski & Associates Portfolio holdings
AUM
$376M
1-Year Est. Return
19.08%
This Fund
S&P 500
This Quarter
Est. Return
+9.82%
1 Year Est. Return
+19.08%
3 Year Est. Return
+84.25%
5 Year Est. Return
+122.72%
10 Year Est. Return
–
AUM
$350M
AUM Growth
+$29.5M
(+9.2%)
Cap. Flow
+$4.37M
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
42.84%
Holding
109
New
5
Increased
54
Reduced
45
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963K |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$713K |
| 3 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$259K |
| 4 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$241K |
| 5 |
Oracle
ORCL
|
+$222K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$215K |
| 2 |
Apple
AAPL
|
+$174K |
| 3 |
Philip Morris
PM
|
+$125K |
| 4 |
AbbVie
ABBV
|
+$106K |
| 5 |
IBM
IBM
|
+$88.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.66% |
| 2 | Consumer Staples | 8.09% |
| 3 | Financials | 7.19% |
| 4 | Industrials | 6.9% |
| 5 | Utilities | 5.1% |
Similar funds
NELSF
MFGP
BCCM
PA
BWA
PAWA
CPA
AACP
Shilanski & Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Shilanski & Associates held 109 positions worth $350M, up 9.2% from $321M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Shilanski & Associates's Q2 2025 filing shows 5 new, 54 increased, 45 reduced and 1 closed positions. Its largest new stake was Oracle: 1,376 shares worth $301K. The largest sale was Merck, an estimated $215K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Staples and Financials.
- Shilanski & Associates's largest Q2 2025 buy was Oracle: 1,376 shares worth $301K.
- Shilanski & Associates added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $963K increase.
- Shilanski & Associates's biggest Q2 2025 reduction was Apple, cutting an estimated $174K.
- Shilanski & Associates fully exited Merck in Q2 2025, selling an estimated $215K.
- Shilanski & Associates's ten largest holdings make up 43% of its $350M portfolio in Q2 2025.
- Shilanski & Associates opened 5 new positions and closed 1 in Q2 2025.
- Shilanski & Associates's portfolio value rose 9.2% quarter-over-quarter to $350M.
Based on Shilanski & Associates's 13F filing for Q2 2025, filed 1 Aug 2025.